Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing critical chemical compounds for research and therapeutic development. Vorinostat, a potent inhibitor of histone deacetylases (HDACs), is one such compound that holds immense significance in the pharmaceutical landscape. This article offers a detailed examination of Vorinostat, its fundamental HDAC inhibitor properties, and its diverse therapeutic applications.
Vorinostat, identified by its CAS number 149647-78-9, functions by inhibiting histone deacetylase enzymes. These enzymes play a crucial role in regulating gene expression by removing acetyl groups from histone proteins, thus influencing chromatin structure and accessibility to DNA. By inhibiting HDACs, Vorinostat promotes histone acetylation, leading to a more relaxed chromatin state and the transcriptional activation of genes that can induce cell differentiation, cell cycle arrest, and apoptosis. This intricate vorinostat mechanism of action is central to its anti-cancer effects.
Clinically, Vorinostat is recognized for its approved use in treating cutaneous manifestations of CTCL (cutaneous T-cell lymphoma) that have not responded to prior systemic treatments. This indication highlights its effectiveness in a challenging hematological malignancy. The continuous progress in vorinostat clinical trials is gradually expanding our understanding of its efficacy across a spectrum of cancers, including brain tumors, lung cancer, and myelodysplastic syndromes, as well as in the context of HIV latency reversal.
For researchers and pharmaceutical companies, securing a reliable supply of Vorinostat is paramount. When considering where to buy Vorinostat powder, partnering with a reputable Vorinostat supplier China is crucial for ensuring product quality and consistency. Factors such as the overall Vorinostat price are also important considerations for project planning and budget management.
Beyond its established role in oncology, Vorinostat is being investigated for its potential in treating other diseases. Its ability to modulate gene expression and cellular processes is being explored in the context of cystic fibrosis, where it may help restore protein function, and in Niemann-Pick type C1 disease, a rare lysosomal storage disorder. These investigations underscore the broad therapeutic potential of Vorinostat, positioning it as a key compound in pharmaceutical research.
NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to empowering scientific discovery by providing high-quality pharmaceutical intermediates. Our commitment to excellence ensures that researchers have access to compounds like Vorinostat, facilitating advancements in medicine and patient care.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
